(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.
To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Baudner BC et al. | MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). | 2009 | Pharm. Res. | pmid:19255727 |
Fox CB et al. | Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. | 2011 | Pharm Dev Technol | pmid:20550484 |
Ott G et al. | MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. | 1995 | Pharm Biotechnol | pmid:7551221 |
Adrangui M et al. | [Water-surfactant-oil diagrams based on perhydrosqualene and triglycerides (Miglyol 812). Study of emulsion phases and stability]. | 1979 | Pharm Acta Helv | pmid:515109 |
Vesikari T et al. | Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. | 2010 | Pediatrics | pmid:20819892 |
Esposito S et al. | Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. | 2011 | Pediatrics | pmid:21464195 |
Ketomäki A et al. | Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia. | 2003 | Pediatr. Res. | pmid:12612218 |
Vesikari T et al. | Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. | 2009 | Pediatr. Infect. Dis. J. | pmid:19561422 |
Huber VC and McCullers JA | Vaccines against pandemic influenza: what can be done before the next pandemic? | 2008 | Pediatr. Infect. Dis. J. | pmid:18820570 |
Langley JM et al. | Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. | 2012 | Pediatr. Infect. Dis. J. | pmid:22801094 |
Block SL et al. | Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. | 2012 | Pediatr. Infect. Dis. J. | pmid:22481427 |
Mitchell DK et al. | Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers. | 2002 | Pediatr. Infect. Dis. J. | pmid:11840080 |
Nassim C et al. | Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. | 2012 | Pediatr. Infect. Dis. J. | pmid:22418661 |
Gavaldà J et al. | Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. | 2013 | Pediatr Transplant | pmid:23692602 |
Lee KH et al. | Squalene aspiration pneumonia in children: radiographic and CT findings as the first clue to diagnosis. | 2005 | Pediatr Radiol | pmid:15806404 |
Kim ES et al. | Squalene-induced exogenous lipoid pneumonia in an infant. | 2009 | Pediatr Int | pmid:19799746 |
Saint-Léger D | [Normal and pathologic sebaceous function. Research in a shallow milieu?]. | 2003 | Pathol. Biol. | pmid:14567194 |
Bouissou H et al. | [Cutaneous cholesterol and phospholipids in atherosclerosis]. | 1976 | Paroi Arterielle | pmid:1012738 |
Elnaiem DA et al. | Chemical factors controlling oviposition of Lutzomyia longipalpis (Diptera: Psychodidae). | 1991 | Parassitologia | pmid:1841210 |
Burkhart CN et al. | Cerumen composition by flash pyrolysis-gas chromatography/mass spectrometry. | 2001 | Otol. Neurotol. | pmid:11698786 |
Hess BA | Formation of the C ring in the lanosterol biosynthesis from squalene. | 2003 | Org. Lett. | pmid:12529131 |
Tanaka H et al. | Enzymatic formation of indole-containing unnatural cyclic polyprenoids by bacterial squalene:hopene cyclase. | 2005 | Org. Lett. | pmid:16354088 |
Tanaka H et al. | 1-methylidenesqualene and 25-methylidenesqualene as active-site probes for bacterial squalene:hopene cyclase. | 2004 | Org. Lett. | pmid:14986979 |
Hoshino T et al. | β-Amyrin biosynthesis: the critical role of steric volume at C-19 of 2,3-oxidosqualene for its correct folding to generate the pentacyclic scaffold. | 2014 | Org. Lett. | pmid:24960408 |
Morimoto Y et al. | Biomimetic epoxide-opening cascades of oxasqualenoids triggered by hydrolysis of the terminal epoxide. | 2013 | Org. Lett. | pmid:23721415 |
Lodeiro S et al. | A putative precursor of isomalabaricane triterpenoids from lanosterol synthase mutants. | 2006 | Org. Lett. | pmid:16435854 |
Winne JM et al. | Application of the B-alkyl suzuki-miyaura cross-coupling reaction to the stereoselective synthesis of analogues of (3S)-oxidosqualene. | 2006 | Org. Lett. | pmid:17020310 |
Segura MJ et al. | Arabidopsis thaliana LUP1 converts oxidosqualene to multiple triterpene alcohols and a triterpene diol. | 2000 | Org. Lett. | pmid:10930257 |
Xiong Z et al. | A short total synthesis of (+)-omaezakianol via an epoxide-initiated cationic cascade reaction. | 2010 | Org. Lett. | pmid:20218639 |
Yang P et al. | Two concise enantioselective total syntheses of (-)-glabrescol implicate alternative biosynthetic pathways starting from squalene. | 2012 | Org. Lett. | pmid:22817611 |
Hess BA and Smentek L | Concerted nature of AB ring formation in the enzymatic cyclization of squalene to hopenes. | 2004 | Org. Lett. | pmid:15151397 |
Hoshino T and Ohashi S | Importance of the methyl group at C10 of squalene for hopene biosynthesis and novel carbocyclic skeletons with 6/5 + 5/5 + (6) ring system(s). | 2002 | Org. Lett. | pmid:12123374 |
Liu YT et al. | Protein engineering of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase into parkeol synthase. | 2012 | Org. Lett. | pmid:23043506 |
Abe T and Hoshino T | Enzymatic cyclizations of squalene analogs with threo- and erythro-diols at the 6,7- or 10,11-positions by recombinant squalene cyclase. Trapping of carbocation intermediates and mechanistic insights into the product and substrate specificities. | 2005 | Org. Biomol. Chem. | pmid:16106294 |
Cheng J and Hoshino T | Cyclization cascade of the C33-bisnorheptaprenoid catalyzed by recombinant squalene cyclase. | 2009 | Org. Biomol. Chem. | pmid:19343258 |
Matsuda SP et al. | Mechanistic insights into triterpene synthesis from quantum mechanical calculations. Detection of systematic errors in B3LYP cyclization energies. | 2006 | Org. Biomol. Chem. | pmid:16446812 |
Morimoto Y et al. | Two-directional synthesis and stereochemical assignment toward a C2 symmetric oxasqualenoid (+)-intricatetraol. | 2006 | Org. Biomol. Chem. | pmid:17036107 |
Winne JM et al. | Nonenzymic polycyclization of analogues of oxidosqualene with a preformed C-ring. | 2008 | Org. Biomol. Chem. | pmid:18480904 |
Nakano S et al. | Squalene-hopene cyclase: insight into the role of the methyl group on the squalene backbone upon the polycyclization cascade. Enzymatic cyclization products of squalene analogs lacking a 26-methyl group and possessing a methyl group at C7 or C11. | 2004 | Org. Biomol. Chem. | pmid:15254628 |
Hoshino T et al. | Squalene-hopene cyclase: final deprotonation reaction, conformational analysis for the cyclization of (3R,S)-2,3-oxidosqualene and further evidence for the requirement of an isopropylidene moiety both for initiation of the polycyclization cascade and for the formation of the 5-membered E-ring. | 2004 | Org. Biomol. Chem. | pmid:15136801 |
Morimoto Y | The role of chemical synthesis in structure elucidation of oxasqualenoids. | 2008 | Org. Biomol. Chem. | pmid:18452003 |
Hoshino T et al. | Production of epoxydammaranes by the enzymatic reactions of (3R)- and (3S)-2,3-squalene diols and those of 2,3:22,23-dioxidosqualenes with recombinant squalene cyclase and the mechanistic insight into the polycyclization reactions. | 2007 | Org. Biomol. Chem. | pmid:17315066 |
O'Neill HJ and Gershbein LL | Lipids of human and equine smegma. | 1976 | Oncology | pmid:1018879 |
Peltola P et al. | Visceral obesity is associated with high levels of serum squalene. | 2006 | Obesity (Silver Spring) | pmid:16899796 |
Ostlund RE et al. | Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. | 2002 | Nutr. Rev. | pmid:12462517 |
Cabrera-Vique C et al. | Bioactive compounds and nutritional significance of virgin argan oil--an edible oil with potential as a functional food. | 2012 | Nutr. Rev. | pmid:22537213 |
SQUALENE, a precursor of cholesterol. | 1954 | Nutr. Rev. | pmid:13166142 | |
Madani KA | Effects of trace components of dietary fat on cholesterol metabolism: phytosterols, oxysterols, and squalene. | 2003 | Nutr. Rev. | pmid:12795450 |
SQUALENE and cholesterol synthesis in the human skin. | 1956 | Nutr. Rev. | pmid:13309889 | |
Nissinen MJ et al. | Effects of plant stanol esters supplied in a fat free milieu by pastilles on cholesterol metabolism in colectomized human subjects. | 2006 | Nutr Metab Cardiovasc Dis | pmid:16935701 |
Scolastici C et al. | Squalene does not exhibit a chemopreventive activity and increases plasma cholesterol in a Wistar rat hepatocarcinogenesis model. | 2004 | Nutr Cancer | pmid:15572303 |
MELCHIORRI-SANTOLINI U and RENZINI G | [Detection of sterols and squalene in sporigenic bacteria]. | 1960 Nov-Dec | Nuovi Ann Ig Microbiol | pmid:13769177 |
RENZINI G | [Detection of sterols and squalene in B. coli aerogenes]. | 1960 Nov-Dec | Nuovi Ann Ig Microbiol | pmid:13740904 |
Allain V et al. | Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices. | 2012 | Nucleic Acids Res. | pmid:22075995 |
Imaeda K et al. | [Effect of sex-hormone on composition of rat skin surface lipid]. | 1987 | Nippon Yakurigaku Zasshi | pmid:3428773 |
Shimizu Y et al. | [Innovation of vaccine adjuvants]. | 2008 | Nippon Rinsho | pmid:18939490 |
Uotani J | [The changes of sterol in lenses]. | 1984 | Nippon Ganka Gakkai Zasshi | pmid:6711397 |
Nishimura S | [Fasting serum squalene in patients with gallstones and hyperlipidemia]. | 1988 | Nihon Shokakibyo Gakkai Zasshi | pmid:3385962 |
Yoshino K and Matsuo I | [Squalene peroxide formation by UVA irradiation with or without 8-MOP (author's transl)]. | 1981 | Nihon Hifuka Gakkai Zasshi | pmid:6971356 |
Torinuki W et al. | [Emission spectral analysis of ultraweak chemiluminescence from linolenic acid and squalene peroxides (author's transl)]. | 1982 | Nihon Hifuka Gakkai Zasshi | pmid:6978954 |
Inomata N | [Symposium I: aging and the activity of the sebaceous glands]. | 1973 | Nihon Hifuka Gakkai Zasshi | pmid:4546667 |
Xue Z et al. | Divergent evolution of oxidosqualene cyclases in plants. | 2012 | New Phytol. | pmid:22150097 |
Inagaki YS et al. | Investigation of the potential for triterpene synthesis in rice through genome mining and metabolic engineering. | 2011 | New Phytol. | pmid:21501172 |
Petrik MS et al. | Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. | 2007 | Neuromolecular Med. | pmid:17114826 |
Paoletti P et al. | Lipid biosynthesis from labelled precursors in an experimental brain tumor-bearing mouse. | 1966 | Neurochirurgia (Stuttg) | pmid:5966653 |
Johnson RC and Shah SN | Metabolism of intracerebrally injected mevalonate in brain of suckling and young adult rats. | 1985 | Neurochem. Res. | pmid:3925358 |
Esposito S et al. | An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. | 2011 | Nephrol. Dial. Transplant. | pmid:20974645 |
Das B et al. | Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. | 2008 | Neoplasia | pmid:18813359 |
Autrum H et al. | [Squalene in the glandular secretion of mammals]. | 1968 | Naturwissenschaften | pmid:5726004 |
Wadman M | Race is on for flu vaccine. | 2005 | Nature | pmid:16267526 |
Thoma R et al. | Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. | 2004 | Nature | pmid:15525992 |
Clark RP and Shirley SG | Identification of skin in airborne particulate matter. | 1973 | Nature | pmid:4585846 |
LUCY JA and DINGLE JT | FAT-SOLUBLE VITAMINS AND BIOLOGICAL MEMBRANES. | 1964 | Nature | pmid:14222261 |
WOOTTON JM and WRIGHT LD | Biosynthesis of squalene by the annelid Lumbricus terrestris. | 1960 | Nature | pmid:13786660 |
ALAM SQ et al. | Detection and estimation of squalene in leaves. | 1962 | Nature | pmid:13860005 |
Bird CW et al. | Steroids and squalene in Methylococcus capsulatus grown on methane. | 1971 | Nature | pmid:4929985 |
GOSSELIN L et al. | Particulate enzyme system for the synthesis of squalene from 2-(14C)-mevalonic acid. | 1962 | Nature | pmid:13900654 |
Phytochemistry: terpenoids for progress. | 1970 | Nature | pmid:5437511 | |
Lewis RW | Distribution of dietary squalene in a wandering Albatross, diomedea exultans. | 1969 | Nature | pmid:5358352 |
Boyd GS and Onajobi FD | Control of cholesterol biosynthesis by a plasma apo-lipoprotein. | 1969 | Nature | pmid:5789314 |
Brassell SC et al. | Specific acyclic isoprenoids as biological markers of methanogenic bacteria in marine sediments. | 1981 | Nature | pmid:7219553 |
HELLER JH et al. | Squalene content of various shark livers. | 1957 | Nature | pmid:13430738 |
Ackman RG et al. | Unusual occurrence of squalene in a fish, the eulachon Thaleichthys pacificus. | 1968 | Nature | pmid:5701840 |
Naughton C et al. | Transcription forms and remodels supercoiling domains unfolding large-scale chromatin structures. | 2013 | Nat. Struct. Mol. Biol. | pmid:23416946 |
Ali NA et al. | Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. | 2010 | Nat. Prod. Res. | pmid:21104527 |
Harrison DM | The biosynthesis of triterpenoids and steroids. | 1985 | Nat Prod Rep | pmid:3913885 |
Abe I et al. | Inhibitors of squalene biosynthesis and metabolism. | 1994 | Nat Prod Rep | pmid:15200015 |
Connolly JD and Hill RA | Triterpenoids. | 2002 | Nat Prod Rep | pmid:12195814 |
Zhang XH et al. | Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods. | 2012 | Nat Prod Commun | pmid:22428257 |
Pili B et al. | Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation. | 2010 | Nanoscale | pmid:20820745 |
Réjiba S et al. | Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. | 2011 | Nanomedicine | pmid:21419876 |
Couvreur P et al. | Squalenoyl nanomedicines as potential therapeutics. | 2006 | Nano Lett. | pmid:17090088 |
Finotti E et al. | Synergistic effects of alpha-tocopherol, beta-sitosterol and squalene on antioxidant activity assayed by crocin bleaching method. | 2000 | Nahrung | pmid:11075383 |
Clark TW et al. | Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | 2009 | N. Engl. J. Med. | pmid:19745215 |
Ambrose CS and Belshe RB | Influenza vaccine in young children. | 2012 | N. Engl. J. Med. | pmid:22276839 |
Heikkinen T and Heinonen S | Influenza vaccine in young children. | 2012 | N. Engl. J. Med. | pmid:22276840 |
Sancho A et al. | More on influenza vaccine in young children. | 2012 | N. Engl. J. Med. | pmid:22738111 |
Miettinen TA et al. | Serum squalene and methyl sterols. | 1970 | N. Engl. J. Med. | pmid:5470273 |
Gallin JI et al. | Increased serum levels of seualene in patients with acute influenza. | 1970 | N. Engl. J. Med. | pmid:5442630 |
Villee CA | Shark oil and medicine. | 1970 | N. Engl. J. Med. | pmid:5462581 |